KURA
Kura Oncology Inc
NASDAQ: KURA · HEALTHCARE · BIOTECHNOLOGY
$8.83
+0.91% today
Updated 2026-04-30
Market cap
$776.67M
P/E ratio
—
P/S ratio
11.51x
EPS (TTM)
$-3.18
Dividend yield
—
52W range
$5 – $12
Volume
1.5M
Kura Oncology Inc (KURA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |